ReviewCurrent hematologic malignancy reports2020
Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and Challenges.
Review in Current hematologic malignancy reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Urologists and social media: pitfalls and perils and what to think about before hitting 'send'.BJU international · 2025Review
- Understanding the online landscape of cannabis discourse: a Twitter analysis.Frontiers in public health · 2025Article
- Exploring Public Emotions on Obesity During the COVID-19 Pandemic Using Sentiment Analysis and Topic Modeling: Cross-Sectional Study.Journal of medical Internet research · 2024Article
- Using Twitter (X) to Mobilize Knowledge for First Contact Physiotherapists: Qualitative Study.Journal of medical Internet research · 2024Article
- Physician-scientists or celebrities? Kardashian-index of gastroenterologists.World journal of methodology · 2023Article
- Virtual Models Using Augmented Reality May Provide a Suitable Supplement, Although Not a Physical Specimen Replacement, in Pathology Education.Medical science educator · 2023Article
- The dramatic increase in anti-vaccine discourses during the COVID-19 pandemic: a social network analysis of Twitter.Human vaccines & immunotherapeutics · 2022Article
- Physician-Scientists: Fixing the Leaking Pipeline - A Scoping Review.Medical science educator · 2022Article
- Physicians' Perspective of Telemedicine Regulating Guidelines and Ethical Aspects: A Saudi Experience.International journal of telemedicine and applications · 2022Article
- Article
- #MedTwitter: An Open Source Medical Community.MedEdPublish (2016) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewSocial media platforms such as Twitter are increasingly utilized to interact, collaborate, and exchange information within the academic medicine community. However, as Twitter begins to become formally incorporated into professional meetings, educational activities, and even the consideration of academic promotion, it is critical to better understand both the benefits and challenges posed by this platform. RECENT
findingsTwitter use is rising amongst healthcare providers nationally and internationally, including in the field of hematology and oncology. Participation on Twitter at national conferences such as the annual meetings of American Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO) has steadily increased over recent years. Tweeting can be used advantageously to cultivate opportunities for networking or collaboration, promote one's research and increase access to other's research, and provide efficient means of learning and educating. However, given the novelty of this platform and little formal training on its use, concerns regarding patient privacy, professionalism, and equity must be considered. These new technologies present unique opportunities for career development, networking, research advancement, and efficient learning. From "tweet ups" to Twitter journal clubs, physician-scientists are quickly learning how to capitalize on the opportunities that this medium offers. Yet caution must be exercised to ensure that the information exchanged is valid and true, that professionalism is maintained, that patient privacy is protected, and that this platform does not reinforce preexisting structural inequalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.